Haystack Medical develops ultra-sharp microneedles for minimally invasive inner-ear drug delivery and diagnostics, opening access through the round window membrane. The company’s work is grounded in a 20-plus-publication research record and is led by clinicians, engineers, and scientists, including otologist Anil K. Lalwani and microscale-device experts Aykut Aksit and Jeffrey W. Kysar.
Financial Conflict of Interest Policy
Compliance program
Otomagnetics, IncOtomagnetics is developing a magnetic injection drug-delivery platform that uses a proprietary magnetic device and biodegradable particles to move therapies non-invasively into hard-to-reach ear and eye tissues. Founded by hearing and neuroscience researcher Didier Depireux, the Gaithersburg company has demonstrated delivery to inner- and middle-ear compartments in animal models, including middle-ear delivery without puncturing the eardrum. Its multidisciplinary team includes CEO Abhita Batra and Chief Medical Officer Karen Stierman, an otolaryngologist with an electrical-engineering background.GAITHERSBURG, MD
Nupur Technologies, LLCNupur Technologies, LLC makes the Earigator®, a self-contained cerumen-management system that combines an otoscope with temperature- and pressure-controlled ear irrigation. Designed by an otologist, the Buffalo company’s patented device lets trained nurses and clinicians remove impacted earwax efficiently within practices, care facilities, and urgent-care settings. Its body-temperature water control and illuminated magnifying handpiece are built around a gentler, more visible alternative to traditional ear-cleaning methods.AMHERST, NY
Congruence Medical Solutions LLCBaltimore-based Congruence Medical Solutions designs, develops and supplies drug-delivery devices that add precision and usability to standard prefillable syringes and other primary containers. The company is especially known for its award-winning Microliter Dosing Syringe, developed for difficult small-volume injections and recognized with the 2019 PDA Drug Delivery Innovation Award in partnership with Santen Pharmaceutical. Its platforms also address viscous and variable-dose therapies, home injection, and drug waste from vials, including through the ELDO™ technology selected for the Johnson & Johnson Innovation–JLABS and BARDA BLUE KNIGHT program.BALTIMORE, MD